KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) FCF Margin (2016 - 2025)

Historic FCF Margin for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to 25.1%.

  • BeOne Medicines' FCF Margin rose 196400.0% to 25.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.95%, marking a year-over-year increase of 409400.0%. This contributed to the annual value of 16.62% for FY2024, which is 533100.0% up from last year.
  • Latest data reveals that BeOne Medicines reported FCF Margin of 25.1% as of Q3 2025, which was up 196400.0% from 16.98% recorded in Q2 2025.
  • BeOne Medicines' FCF Margin's 5-year high stood at 25.1% during Q3 2025, with a 5-year trough of 305.88% in Q2 2021.
  • In the last 5 years, BeOne Medicines' FCF Margin had a median value of 59.68% in 2023 and averaged 74.7%.
  • In the last 5 years, BeOne Medicines' FCF Margin surged by 7212200bps in 2021 and then plummeted by -1213000bps in 2022.
  • BeOne Medicines' FCF Margin (Quarter) stood at 5.66% in 2021, then crashed by -2143bps to 115.64% in 2022, then surged by 48bps to 59.68% in 2023, then surged by 97bps to 1.54% in 2024, then surged by 1734bps to 25.1% in 2025.
  • Its FCF Margin stands at 25.1% for Q3 2025, versus 16.98% for Q2 2025 and 1.43% for Q1 2025.